Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Booth Andrew, Chief Financial Officer. Officer active across 1 company, notably AbCellera Biologics Inc.. In total, 10 filings have been published. Breakdown: 5 buys · 1 sell. Total volume traded: €26.8m. Activity tracked since 7 June 2021. The latest transaction was filed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Booth Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
600,000 shares@ US$0.190.3% of flowCommon SharesSEC:0000899243-21-022894:0
10 of 10 declarations
About Booth Andrew
Booth Andrew is Directeur Financier at AbCellera Biologics Inc. He has 9 filings in total, and across the sampled recent filings from 2021-06-09 to 2026-06-03, buys amount to EUR 1376774 and sells to EUR 25119019, with Levée d'options as the most frequent transaction type.